GAITHERSBURG, Md., March 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company will release financial results for the fourth quarter and fiscal year ended December 31, 2010, following the close of the market on Wednesday, March 30, 2011.
